Active, Not Recruiting
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
NCT05141682
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- University of Virginia Charlottesville, Virginia, United States